The specificity of neuroleptic- and methysergide-induced behavioral hypersensitivity.
D006916:5-Hydroxytryptophan / Q000037:antagonists & inhibitors; D000661:Amphetamine / Q000037:antagonists & inhibitors; D000818:Animals; D001058:Apomorphine / Q000037:antagonists & inhibitors; D001522:Behavior, Animal / Q000187:drug effects*; D002746:Chlorpromazine / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D006168:Guinea Pigs; D006220:Haloperidol / Q000494:pharmacology*; D006801:Humans; D008297:Male; D008784:Methysergide / Q000494:pharmacology*; D009043:Motor Activity / Q000187:drug effects; D011954:Receptors, Dopamine / Q000187:drug effects; D011985:Receptors, Serotonin / Q000187:drug effects; D013239:Stereotyped Behavior / Q000187:drug effects
D011954:Receptors, Dopamine; D011985:Receptors, Serotonin; D006916:5-Hydroxytryptophan; D000661:Amphetamine; D006220:Haloperidol; D001058:Apomorphine; D002746:Chlorpromazine; D008784:Methysergide